M&A Deal Summary |
|
|---|---|
| Date | 2021-03-17 |
| Target | Interpace Biosciences - CLIA Lab |
| Sector | Healthcare Services |
| Buyer(s) | DiamiR |
| Sellers(s) | Interpace |
| Deal Type | Divestiture |
SEARCH BY
DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient stratification, as well as disease progression, and treatment monitoring. DiamiR collaborates with leading academic centers, disease foundations, and biopharma companies. DiamiR is based in Monmouth Junction, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1986 |
| Sector | Life Science |
| Employees | 111 |
| Revenue | 47M USD (2024) |
Interpace engages in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Interpace Biosciences was founded in 1986 and is based in Parsippany, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 2 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-15 |
Cancer Genetics - Biopharma Services Business
New Jersey, United States Cancer Genetics, Inc. - Biopharma Services Business is a provider of molecular and biomarker-based tests for oncology and immuno-oncology drug development customers operating out of existing laboratories in Rutherford, NJ and Research Triangle Park, NC. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-08-31 |
Interpace Pharma Solutions
Research Triangle Park, North Carolina, United States Interpace Pharma Solutions provides complex molecular analysis services supporting clinical trials and diagnostic development. These services include genomic profiling, biomarker solutions, project and data management, bioinformatics analysis, and biorepository services. Interpace Pharma Solutions is based in Research Triangle Park, North Carolina. |
Sell | - |
